150 related articles for article (PubMed ID: 8895200)
21. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists.
Chaudhary PM; Roninson IB
Oncol Res; 1992; 4(7):281-90. PubMed ID: 1360276
[TBL] [Abstract][Full Text] [Related]
22. In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells.
Dong ZY; Ward NE; Fan D; Gupta KP; O'Brian CA
Mol Pharmacol; 1991 Apr; 39(4):563-9. PubMed ID: 2017156
[TBL] [Abstract][Full Text] [Related]
23. Phorbol ester-induced cell death in PC-12 cells overexpressing Bcl-2 is dependent on the time at which cells are treated.
Hahn MA; Mayne GC
Cell Biol Int; 2004; 28(5):345-59. PubMed ID: 15193278
[TBL] [Abstract][Full Text] [Related]
24. Expression and activation of protein kinase C isoforms in a human megakaryocytic cell line.
Ballen KK; Ritchie AJ; Murphy C; Handin RI; Ewenstein BM
Exp Hematol; 1996 Nov; 24(13):1501-8. PubMed ID: 8950233
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract.
Limtrakul P; Khantamat O; Pintha K
Cancer Chemother Pharmacol; 2004 Dec; 54(6):525-30. PubMed ID: 15248030
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of 12-O-tetradecanoyl-13-phorbol acetate (TPA) on growth, migration and invasion of a human glioma cell line.
Tysnes OB; Laerum OD
Anticancer Res; 1993; 13(5A):1325-30. PubMed ID: 8239502
[TBL] [Abstract][Full Text] [Related]
27. Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells.
Aftab DT; Yang JM; Hait WN
Oncol Res; 1994; 6(2):59-70. PubMed ID: 7949466
[TBL] [Abstract][Full Text] [Related]
28. [Correlation of protein kinase C activity and its subcellular distrubution with multidrug resistance in KVB200 cells].
Sun AM; Yuan YW; Li CG; Chen J; Xiao MX; Zhao MF
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):121-3. PubMed ID: 12390803
[TBL] [Abstract][Full Text] [Related]
29. Immunocytochemical evidence for phorbol ester-induced directional translocations of protein kinase C in HL60, K562, CHO, and E7SKS cells: possible role in differentiation.
Girard PR; Stevens VL; Blackshear PJ; Merrill AH; Wood JG; Kuo JF
Cancer Res; 1987 Jun; 47(11):2892-8. PubMed ID: 3552209
[TBL] [Abstract][Full Text] [Related]
30. Phorbol ester-induced alteration of differentiation and proliferation in human hematopoietic tumor cell lines: relationship to the presence and subcellular distribution of protein kinase C.
Forsbeck K; Nilsson K; Hansson A; Skoglund G; Ingelman-Sundberg M
Cancer Res; 1985 Dec; 45(12 Pt 1):6194-9. PubMed ID: 4063970
[TBL] [Abstract][Full Text] [Related]
31. Effects of phorbol ester on translocation and down-regulation of protein kinase C and phosphorylation of endogenous proteins in human acute myeloid leukemia cell line KG-1 and its phorbol ester-resistant subline KG-1a.
Shoji M; Girard PR; Charp PA; Koeffler HP; Vogler WR; Kuo JF
Cancer Res; 1987 Dec; 47(23):6363-70. PubMed ID: 3479244
[TBL] [Abstract][Full Text] [Related]
32. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug-resistant human KB cells.
Chambers TC; Zheng B; Kuo JF
Mol Pharmacol; 1992 Jun; 41(6):1008-15. PubMed ID: 1377325
[TBL] [Abstract][Full Text] [Related]
33. Adhesiveness and proliferation of epithelial cells are differentially modulated by activation and inhibition of protein kinase C in a substratum-dependent manner.
Zhou Y; Dziak E; Opas M
J Cell Physiol; 1993 Apr; 155(1):14-26. PubMed ID: 8468359
[TBL] [Abstract][Full Text] [Related]
34. Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms.
Urasaki Y; Ueda T; Yoshida A; Fukushima T; Takeuchi N; Tsuruo T; Nakamura T
Anticancer Res; 1996; 16(2):709-14. PubMed ID: 8687117
[TBL] [Abstract][Full Text] [Related]
35. Depletion of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cells.
Isonishi S; Ohkawa K; Tanaka T; Howell SB
Br J Cancer; 2000 Jan; 82(1):34-8. PubMed ID: 10638963
[TBL] [Abstract][Full Text] [Related]
36. Effect of bisbenzylisoquinoline (biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells.
Shiraishi N; Akiyama S; Nakagawa M; Kobayashi M; Kuwano M
Cancer Res; 1987 May; 47(9):2413-6. PubMed ID: 3567927
[TBL] [Abstract][Full Text] [Related]
37. PKC-independent modulation of multidrug resistance in cells with mutant (V185) but not wild-type (G185) P-glycoprotein by bryostatin 1.
Spitaler M; Utz I; Hilbe W; Hofmann J; Grunicke HH
Biochem Pharmacol; 1998 Oct; 56(7):861-9. PubMed ID: 9774148
[TBL] [Abstract][Full Text] [Related]
38. Protein kinase C activation inhibits glutamate transport by endothelial cells.
Pan M; Wasa M; Souba WW
J Surg Res; 1995 Jun; 58(6):630-5. PubMed ID: 7791339
[TBL] [Abstract][Full Text] [Related]
39. Effects of MDR reversing agent combinations on the 3H-daunomycin accumulation in drug-sensitive and drug-resistant human cancer cells.
Moins N; Cayre A; Chevillard S; Maublant J; Verrelle P; Finat-Duclos F
Anticancer Res; 2000; 20(4):2617-23. PubMed ID: 10953334
[TBL] [Abstract][Full Text] [Related]
40. Effects of protein kinase C modulators on multidrug resistance in human glioma cells.
Matsumoto T; Tani E; Yamaura I; Miyaji K; Kaba K
Neurosurgery; 1995 Mar; 36(3):565-71; discussion 572. PubMed ID: 7538636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
